Putnam Investments LLC Seagen Inc. Transaction History

Putnam Investments LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $6.2 Million - $8.26 Million	-45,836 Reduced 35.64%	82,781 $11.3 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $14 Million - $23.1 Million	128,617 New	128,617 $22.8 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $7.4 Million - $9.77 Million	-61,883 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $4.32 Million - $5.78 Million	-30,267 Reduced 32.85%	61,883 $9.57 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $4.12 Million - $4.91 Million	28,893 Added 45.68%	92,150 $15.6 Million

Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $29.1 Million - $34.8 Million	-215,743 Reduced 77.33%	63,257 $9.99 Million
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $81.1 Million - $113 Million	-589,852 Reduced 67.89%	279,000 $38.7 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $143 Million - $184 Million	868,852 New	868,852 $152 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.